Catalyst Wire Dossier Catalyst Wire Dossier

VRd-based regimen

bortezomib/lenalidomide/dexamethasone
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VRd-based regimen, covering 2025-08-04 to 2025-08-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of VRd-based Regimen Combined With CART-ASCT-CART2 Treatment in NDMM Patients With P53 Abnormalities [Phase 2]

See pricing